BioCentury
ARTICLE | Company News

J&J, WHO infectious news

May 12, 2014 7:00 AM UTC

Johnson & Johnson's Janssen Pharmaceutica N.V. subsidiary partnered with the Stop TB Partnership's Global Drug Facility to provide access to J&J's Sirturo bedaquiline to treat tuberculosis (TB) to ov...